Cullinan oncology stock
WebCullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's … WebSep 14, 2024 · Cullinan Oncology's total cash and short-term investment is $611 million, up 94% from the previous quarter. Click here to read our analysis why CGEM is a buy. …
Cullinan oncology stock
Did you know?
WebApr 5, 2024 · 3 Wall Street research analysts have issued 12-month target prices for Cullinan Oncology's stock. Their CGEM share price forecasts range from $19.00 to … WebMar 9, 2024 · CGEM Cullinan Oncology Inc Annual Report (10-k) SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS. This Annual Report on Form 10-K contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the …
WebApr 13, 2024 · The 10 Best Stocks to Own in 2024 7 Stocks to Buy and Hold Forever 3 Stocks to DOUBLE This Year Pineapple Energy presently has a consensus target price of $5.60, indicating a potential upside of... WebMar 31, 2024 · Cullinan Oncology Stock Price Today (NASDAQ: CGEM) Quote, Market Cap, Chart WallStreetZen Cullinan Oncology Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $10.23 +0.03 (+0.29%) Updated Mar 31, 2024 1W - 2.66% 1M - 9.39% 3M - 4.21% 1Y - 2.29% CGEM Price $10.23 Fair Value Price …
WebApr 1, 2024 · Cullinan Oncology, Inc. has a one year low of $7.30 and a one year high of $15.89. The company’s 50 day moving average price is $11.13 and its 200 day moving average price is $11.69. The firm... WebMar 17, 2024 · Cullinan Oncology grants stock options to employees seekingalpha.com - June 2 at 6:23 AM: Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2024 ASCO Annual Meeting finance.yahoo.com - …
WebCullinan Oncology Targeting Oncology We value your privacy We use cookies to improve your experience on our site. By selecting "Accept", you consent to our use of …
WebCullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer ... gaby roslin radio 2WebFeb 22, 2024 · Dr D CGEM stock SEC Form 4 insiders trading. Dr has made over 4 trades of the Cullinan Oncology stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 11,000 units of CGEM stock worth $47,300 on 8 September 2024.. The largest trade he's ever made was selling 116,929 units of Cullinan Oncology … gaby roofing union city njWebJun 4, 2024 · Cullinan Oncology, Inc. Market Cap (-3.94%) -$0.41 The company announced encouraging clinical data for its experimental lung cancer drug. What … gaby roslin radio showWebBe the first to know when CGEM insiders and whales buy or sell their stock. Get Free CGEM Updates CGEM Shareholders What type of owners hold Cullinan Oncology Inc stock? Institutional Insider Retail 1 of 3 CGEM vs Biotech Stocks View Top Biotech Stocks Cullinan Oncology Stock Ownership FAQ Who owns Cullinan Oncology? gaby roslin instagramWebApr 6, 2024 · Cullinan Oncology currently has issued a total of 39,330,000 shares. Some of Cullinan Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open … gaby rottlebWebCullinan Oncology Stock (NASDAQ:CGEM), Quotes and News Summary. Cullinan Oncology Stock (NASDAQ: CGEM) stock price, news, charts, stock research, profile. gaby roslin affairWebCullinan Oncology (NASDAQ: CGEM) is owned by 95.72% institutional shareholders, 99.45% Cullinan Oncology insiders, and 0.00% retail investors. Ansbert Gadicke is the … gaby roth